Showing results (981-990 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|March 13, 2019
A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary CholangitisMarlyn J Mayo, Paul J Pockros, David Jones, et al.
Hepatology Communications|December 17, 2021
Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey)Lauren Périères, Aldiouma Diallo, Fabienne Marcellin, et al.
Hepatology Communications|December 24, 2021
Immunological Aspects of AXL/GAS-6 in the Context of Human Liver RegenerationGregor Ortmayr, Laura Brunnthaler, David Pereyra, et al.
Hepatology Communications|March 8, 2021
A Population-Based Intervention to Improve Care Cascades of Patients With Hepatitis C Virus InfectionJohn Scott, Meaghan Fagalde, Atar Baer, et al.
Hepatology Communications|March 8, 2021
Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting CirrhosisShalom Z Frager, James Szymanski, Jonathan M Schwartz, et al.
Hepatology Communications|March 8, 2021
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS StudyBertus Eksteen, Christopher L Bowlus, Aldo J Montano-Loza, et al.
Hepatology Communications|November 10, 2018
Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Trial of Synthetic Preimplantation Factor in Autoimmune HepatitisChristopher B O'Brien, Eytan R Barnea, Paul Martin, et al.
Hepatology Communications|November 10, 2018
Treatment of Adolescents With Chronic Hepatitis C Virus Infection: New Regimen on the BlockGiuseppe Indolfi, Silvia Ricci
Hepatology Communications|November 10, 2018
Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4Daniel H Leung, Stefan Wirth, Betty B Yao, et al.
Hepatology Communications|July 16, 2019
Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte-Mediated Paracrine MechanismJordi Gracia-Sancho, Nicolò Manicardi, Martí Ortega-Ribera, et al.
Pageof 179